Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis

ConclusionsWe confirmed the clinical and MRI efficacy of alemtuzumab in the clinical setting and the frequency of infusion-related reactions. Compared with that in clinical trials, higher number of patients developed pneumonitis during infusion.
Source: Journal of Neurology - Category: Neurology Source Type: research